General Information of Drug (ID: DMLAF6C)

Drug Name
SD1002 Drug Info
Indication
Disease Entry ICD 11 Status REF
Alzheimer disease 8A20 Preclinical [1]
Cross-matching ID
TTD Drug ID
DMLAF6C

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Patented Agent(s)
Drug(s) Targeting Cathepsin L (CTSL)
Drug Name Drug ID Indication ICD 11 Highest Status REF
KGP94 DM2NZ6K Coagulation defect 3B10.0 Clinical trial [2]
PMID27998201-Compound-12 DM8QZNC Bone cancer 2B5Z Patented [3]
PMID27998201-Compound-5 DMVZ0ND Chronic obstructive pulmonary disease CA22 Patented [3]
PMID27998201-Compound-9 DM1JOZN Rheumatoid arthritis FA20 Patented [3]
PMID25399719-Compound-17 DMRXKJZ N. A. N. A. Patented [4]
PMID27998201-Compound-17 DMAZVHJ Hair loss ED70 Patented [3]
Phenylalanine derivative 1 DMVYP8K Glioma 2A00.0 Patented [3]
PMID27998201-Compound-7 DMU4QYR Abdominal aortic aneurysm BD50.4 Patented [3]
PMID27998201-Compound-6 DM0LGTY N. A. N. A. Patented [3]
PMID27998201-Compound-1 DM5QH4C Coronavirus infection 1D92 Patented [3]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Targeting Cathepsin B (CTSB)
Drug Name Drug ID Indication ICD 11 Highest Status REF
PMID27998201-Compound-12 DM8QZNC Bone cancer 2B5Z Patented [3]
PMID27998201-Compound-5 DMVZ0ND Chronic obstructive pulmonary disease CA22 Patented [3]
PMID27998201-Compound-9 DM1JOZN Rheumatoid arthritis FA20 Patented [3]
PMID27998201-Compound-17 DMAZVHJ Hair loss ED70 Patented [3]
PMID27998201-Compound-11 DMTV5NU Metastatic cancer 2D50-2E2Z Patented [3]
PMID27998201-Compound-2 DMMAE3C Alzheimer disease 8A20 Patented [3]
PMID27998201-Compound-22 DMS9QA7 Alzheimer disease 8A20 Patented [3]
PMID27998201-Compound-13 DMZHIM8 Hepatic fibrosis DB93.0 Patented [3]
Dimethoxybenzylidene-2-thio-imidazole-4-one derivative 1 DMZ4B3W Cerebral ischemia 8B11 Patented [3]
PMID27998201-Compound-24 DM25BNZ Glioma 2A00.0 Patented [3]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Cathepsin B (CTSB) TTF2LRI CATB_HUMAN Inhibitor [1]
Cathepsin L (CTSL) TT36ETB CATL1_HUMAN Inhibitor [1]

References

1 Lysosomes as a therapeutic target. Nat Rev Drug Discov. 2019 Dec;18(12):923-948.
2 Functionalized benzophenone, thiophene, pyridine, and fluorene thiosemicarbazone derivatives as inhibitors of cathepsin L. Bioorg Med Chem Lett. 2010 Nov 15;20(22):6610-5.
3 Cathepsin B and L inhibitors: a patent review (2010 - present).Expert Opin Ther Pat. 2017 Jun;27(6):643-656.
4 An updated patent review of calpain inhibitors (2012 - 2014).Expert Opin Ther Pat. 2015 Jan;25(1):17-31.